VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,584,000 | +61.0% | 69,003 | +33.6% | 0.17% | +104.8% |
| Q2 2018 | $984,000 | +46.4% | 51,663 | +29.5% | 0.08% | +52.7% |
| Q1 2018 | $672,000 | -65.3% | 39,893 | -68.7% | 0.06% | -28.6% |
| Q4 2017 | $1,935,000 | +14.7% | 127,277 | +35.0% | 0.08% | -51.9% |
| Q3 2017 | $1,687,000 | -14.6% | 94,272 | -22.2% | 0.16% | -10.6% |
| Q2 2017 | $1,975,000 | +5.3% | 121,138 | -9.5% | 0.18% | -12.7% |
| Q1 2017 | $1,875,000 | +1.2% | 133,921 | +15.3% | 0.20% | -9.3% |
| Q4 2016 | $1,853,000 | +62.4% | 116,155 | +69.4% | 0.23% | +80.8% |
| Q3 2016 | $1,141,000 | – | 68,569 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |